CAVERJECT POWDER FOR INJECTION 20 mcg/ml
Product details
Registration number: SIN08097P
Classification: Prescription Only
Active ingredients: ALPROSTADIL
Strength: 20 mcg/ml
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRACAVERNOUS
Registrant: PFIZER PRIVATE LIMITED
ATC code: G04BE01
HSA approval date: 28 March 1995
Manufacturer(s): Pfizer Manufacturing Belgium NV
Manufacturing country/countries: BELGIUM
What are the HSA registration number and classification for CAVERJECT POWDER FOR INJECTION 20 mcg/ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN08097P
Classification: Prescription Only
What active ingredients and strength are recorded for CAVERJECT POWDER FOR INJECTION 20 mcg/ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: ALPROSTADIL
Strength: 20 mcg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for CAVERJECT POWDER FOR INJECTION 20 mcg/ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRACAVERNOUS
Who is the recorded registrant for CAVERJECT POWDER FOR INJECTION 20 mcg/ml?
According to the HSA dataset updated 7 August 2026:
Registrant: PFIZER PRIVATE LIMITED
Which manufacturers and countries are listed for CAVERJECT POWDER FOR INJECTION 20 mcg/ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Pfizer Manufacturing Belgium NV
Manufacturing country/countries: BELGIUM
Where can I look up CAVERJECT POWDER FOR INJECTION 20 mcg/ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN08097P or the exact product name CAVERJECT POWDER FOR INJECTION 20 mcg/ml. The general register link does not preselect this product.
What are the source dates for this CAVERJECT POWDER FOR INJECTION 20 mcg/ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this CAVERJECT POWDER FOR INJECTION 20 mcg/ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN08097P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)